March 12, 2018 / 1:17 AM / 3 months ago

BRIEF-Immutep Ltd Enters Into Clinical Trial Collaboration With Merck & Co

March 12 (Reuters) - Immutep Ltd:

* ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK & CO., INC

* DEAL TO EVALUATE COMBINATION OF IMMUTEP’S IMMUNOTHERAPY PRODUCT CANDIDATE WITH MSD’S ANTI-PD-1 THERAPY KEYTRUDA IN A NEW CLINICAL TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below